BridgeMD
Prevention study for Hiv
Official title PRIDE III Prison Interventions and HIV Prevention Collaboration
ClinicalTrials.gov ID: NCT06962033
What this study is testing
- What it's testing
- The primary objective of this research project is to identify barriers to scale-up of Opioid Agonist Therapy (OAT) in the justice systems (prisons and probation) in Tajikistan, Kyrgyzstan, Moldova, and Georgia, and establish a NIATx learning collaborative to scale-up OAT, and analyze scale-up utilizing latent class growth analyses in people who inject drugs (PWID).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aim 1:
- Quantitative surveys for prison OAT providers
- Being 18 years or older
- Being currently assigned and working as a probation OAT provider for a probation site
- ECHO procedures Aim 2:
See the full eligibility criteria
- Aim 1:
- Quantitative surveys for prison OAT providers
- Being 18 years or older
- Being currently assigned and working as a probation OAT provider for a probation site
- ECHO procedures Aim 2:
- Quantitative surveys for people in probation
- Being 18 years or older
- Screen yes to opioid injection on the online screener questionnaire
- Currently in probation
- Quantitative surveys for probation and prison officers
- Being 18 years or older
- Being currently assigned and working as a probation or prison officer at a probation site
- Focus Groups (People in probation)
- Being 18 years or older
- Screen yes to opioid injection criteria on the online screener
- Currently in probation
- Focus Groups (Probation and prison officers)
- Being 18 years or older
- Being currently assigned and working as a probation or prison officer at a probation
- Has more than 3 months of field experience
- Works at a probation site within 25 kilometers of an OAT site
The study team makes the final eligibility decision.
Where it's taking place
- New Haven, Connecticut, United States
- Tbilisi, Georgia
- Bishkek, Kyrgyzstan
- Chisinau, Moldova
- Dushanbe, Tajikistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Haven, Connecticut, United States; Tbilisi, Georgia; Bishkek, Kyrgyzstan; Chisinau, Moldova; Dushanbe, Tajikistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.